Copyright © 2005, European Society of Cardiology
Abnormal KCNQ1 trafficking influences disease pathogenesis in hereditary long QT syndromes (LQT1)
aBHF Laboratories and Department of Medicine, University College London, 5 University Street, London, WC1E 6JJ, UK
bClinical and Molecular Genetics Unit, Institute of Child Health, 30 Guildford Street, London WC1N 1EH, UK
* Corresponding author. Email address: a.tinker{at}ucl.ac.uk
Objective: In the hereditary long QT syndromes the commonest defect is in the K+ channel pore forming subunit, KCNQ1. In this study we investigated the role that abnormal KCNQ1 trafficking has in the pathogenesis of the hereditary long QT syndrome (LQT1).
Methods: We introduced nine missense and nonsense mutations occurring in LQT1 into the cDNA encoding KCNQ1 fused in frame to the green fluorescent protein. These mutations occur in syndromes that are inherited in both autosomal dominant and recessive fashions. We used biochemistry, electrophysiology and cell imaging to examine the behaviour of wildtype and mutant channel subunits expressed together with the auxiliary subunit KCNE1 expressed in CHO-K1 and C2C12 cells.
Results: We found that a number of mutations in KCNQ1 are retained in the endoplasmic reticulum and unable to translocate to the plasma membrane. Furthermore, some mutations act in a dominant negative fashion and have the ability to suppress the trafficking of wildtype channel. We use fluorescence resonance energy transfer microscopy to show that this occurs because of direct interaction between the mutant subunit and wildtype channel in the endoplasmic reticulum. Finally, a number of specific and nonspecific pharmacological tools are unable to promote the delivery of these mutants to the plasma membrane.
Conclusions: Our data revealed that channel trafficking may contribute to the pathogenesis of LQT1.
KEYWORDS K+ channels; Long QT syndrome; KCNQ1
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Farzaneh and A. Tinker Differences in the mechanism of metabolic regulation of ATP-sensitive K+ channels containing Kir6.1 and Kir6.2 subunits Cardiovasc Res, September 1, 2008; 79(4): 621 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dahimene, S. Alcolea, P. Naud, P. Jourdon, D. Escande, R. Brasseur, A. Thomas, I. Baro, and J. Merot The N-Terminal Juxtamembranous Domain of KCNQ1 Is Critical for Channel Surface Expression: Implications in the Romano-Ward LQT1 Syndrome Circ. Res., November 10, 2006; 99(10): 1076 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Z. Lan, P. Y. T. Wang, and C. E. Hill Modulation of hepatocellular swelling-activated K+ currents by phosphoinositide pathway-dependent protein kinase C Am J Physiol Cell Physiol, July 1, 2006; 291(1): C93 - C103. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Boulet, A. L. Raes, N. Ottschytsch, and D. J. Snyders Functional effects of a KCNQ1 mutation associated with the long QT syndrome Cardiovasc Res, June 1, 2006; 70(3): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bezzina, A. A.M. Wilde, and D. M. Roden The molecular genetics of arrhythmias Cardiovasc Res, August 15, 2005; 67(3): 343 - 346. [Full Text] [PDF] |
||||


